Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 12 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Completed				18 and over				Pharmaceutical / Industry				CA183-002 NCT00389155


2.		Phase III Trial of Vinflunine Plus Best Supportive Care vs. Best Supportive Care in Patients With Transitional Cell Carcinoma (TCC) of the Urothelial Tract

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Closed				18 and over				Pharmaceutical / Industry				L0070 IN 302 P1 CA183004, NCT00315237

Last Modified: 7/10/2007 First Published: 12/16/2005


3.		Phase II Study of Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium That Relapsed or Progressed After Prior Platinum-Based Chemotherapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				Pharmaceutical / Industry				BMS-CA183001 UPCC-07804, NCT00101608


4.		A Phase II Single Arm Trial of Single-Agent Vinflunine as Second-Line Treatment of Advanced Non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				Pharmaceutical / Industry				I-05-009 NCT00251446


5.		Vinflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				Other				SCRI LUN 122 CA183017, NCT00284154


6.		Vinflunine Plus Trastuzumab in HER2 Over-Expressing Metastatic Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				Other				SCRI BRE 89 CA183014, NCT00284180


7.		Study of Vinflunine and Cetuximab to Treat Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Temporarily closed				18 and over				Other				LCCC 0503 NCT00330031

Last Modified: 7/27/2008 First Published: 8/14/2007


8.		Phase II Study of Vinflunine and Cetuximab as Second-Line Therapy in Patients With Stage IIIB or IV Non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				UNC-LCCC-0503 LCCC 0503, NCT00519831


9.		Vinflunine in Hormone Refractory Prostate Cancer (HRPC)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				Other				SCRI GU 35 NCT00545766


10.		A Study of the Alternative Administration of Ixabepilone and Vinflunine

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				18 and over				Pharmaceutical / Industry				CA183-008 NCT00362830

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute